Literature DB >> 23427257

Differential polarization of C-terminal Src kinase between naive and antigen-experienced CD8+ T cells.

Jessica G Borger1, Andrew Filby, Rose Zamoyska.   

Abstract

In CD8(+) T cells, engagement of the TCR with agonist peptide:MHC molecules causes dynamic redistribution of surface molecules including the CD8 coreceptor to the immunological synapse. CD8 associates with the Src-family kinase (SFK) Lck, which, in turn, initiates the rapid tyrosine phosphorylation events that drive cellular activation. Compared with naive T cells, Ag-experienced CD8(+) T cells make shorter contacts with APC, are less dependent on costimulation, and are triggered by lower concentrations of Ag, yet the molecular basis of this more efficient response of memory T cells is not fully understood. In this article, we show differences between naive and Ag-experienced CD8(+) T cells in colocalization of the SFKs and their negative regulator, C-terminal Src kinase (Csk). In naive CD8(+) T cells, there was pronounced colocalization of SFKs and Csk at the site of TCR triggering, whereas in Ag-experienced cells, Csk displayed a bipolar distribution with a proportion of the molecules sequestered within a cytosolic area in the distal pole of the cell. The data show that there is differential redistribution of a key negative regulator away from the site of TCR engagement in Ag-experienced CD8(+) T cells, which might be associated with the more efficient responses of these cells on re-exposure to Ag.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427257      PMCID: PMC4595994          DOI: 10.4049/jimmunol.1202408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  The immunological synapse of CTL contains a secretory domain and membrane bridges.

Authors:  J C Stinchcombe; G Bossi; S Booth; G M Griffiths
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

2.  Reporting imaging flow cytometry data for publication: why mask the detail?

Authors:  Andrew Filby; Derek Davies
Journal:  Cytometry A       Date:  2012-07-03       Impact factor: 4.355

3.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  Antigen receptor engagement delivers a stop signal to migrating T lymphocytes.

Authors:  M L Dustin; S K Bromley; Z Kan; D A Peterson; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn.

Authors:  M W Appleby; J A Gross; M P Cooke; S D Levin; X Qian; R M Perlmutter
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

6.  Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.

Authors:  H Sabe; A Hata; M Okada; H Nakagawa; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions.

Authors:  W van't Hof; M D Resh
Journal:  J Cell Biol       Date:  1999-04-19       Impact factor: 10.539

8.  Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells.

Authors:  M F Bachmann; A Gallimore; S Linkert; V Cerundolo; A Lanzavecchia; M Kopf; A Viola
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

9.  Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.

Authors:  T Brdicka; D Pavlistová; A Leo; E Bruyns; V Korínek; P Angelisová; J Scherer; A Shevchenko; I Hilgert; J Cerný; K Drbal; Y Kuramitsu; B Kornacker; V Horejsí; B Schraven
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Fyn regulates the duration of TCR engagement needed for commitment to effector function.

Authors:  Andrew Filby; Benedict Seddon; Joanna Kleczkowska; Robert Salmond; Peter Tomlinson; Michal Smida; Jonathan A Lindquist; Burkhart Schraven; Rose Zamoyska
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

View more
  6 in total

1.  Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.

Authors:  Duane Moogk; Shi Zhong; Zhiya Yu; Ivan Liadi; William Rittase; Victoria Fang; Janna Dougherty; Arianne Perez-Garcia; Iman Osman; Cheng Zhu; Navin Varadarajan; Nicholas P Restifo; Alan B Frey; Michelle Krogsgaard
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

Review 2.  T cell receptor signalling networks: branched, diversified and bounded.

Authors:  Rebecca J Brownlie; Rose Zamoyska
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

3.  Novel tools to dissect the dynamic regulation of TCR signaling by the kinase Csk and the phosphatase CD45.

Authors:  Ying Xim Tan; Julie Zikherman; Arthur Weiss
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-07

4.  Focal adhesion kinase negatively regulates Lck function downstream of the T cell antigen receptor.

Authors:  Nicole M Chapman; Sean F Connolly; Erin L Reinl; Jon C D Houtman
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

5.  Small molecule inhibition of Csk alters affinity recognition by T cells.

Authors:  Boryana N Manz; Ying Xim Tan; Adam H Courtney; Florentine Rutaganira; Ed Palmer; Kevan M Shokat; Arthur Weiss
Journal:  Elife       Date:  2015-08-24       Impact factor: 8.140

6.  Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells.

Authors:  Jessica G Borger; Rose Zamoyska; Dmitry M Gakamsky
Journal:  Immunol Lett       Date:  2013-11-18       Impact factor: 3.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.